Updates

28th September 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street Bandra-Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 Scrip Code: 500674 Symbol: SANOFI Sub: Disclosure under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 including any statutory modifications or amendments or re-enactments thereof (“SEBI PIT Regulations”) Dear Sir/Madam, With reference to the above captioned subject, we are enclosing herewith the disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI PIT Regulations from Sanofi Healthcare India Private Limited, an entity of the Promoter Group of the Company, in Form B with respect to the purchase of equity shares of the Company from Hoechst GmbH, a Promoter of the Company, by way of inter-se transfer of shares through a block deal mechanism on the Stock Exchange. We are hereby submitting the requisite disclosure under Regulation 7(2)(b) of the SEBI PIT Regulations for your information. This is for your information and records. Thanking you, Yours faithfully For Sanofi India Limited Haresh Vala Company Secretary and Compliance Officer Membership No.: A18246 Encl: As above Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com FORM B SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2) - Continual Disclosure] Name of the Company : Sanofi India Limited ISIN of the Company : INE058A01010 Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2) Name, PAN, Category of Securities held prior to Securities acquired/ disposed Securities held post Date of allotment advice/ Date of Mode of Exchange on CIN/DIN, & Person acquisition/ Disposal acquisition/ Disposal acquisition of shares/ disposal intimation to acquisition/ which the trade address with (Promoters/ of shares, specify Company disposal (on was executed contact nos. Member of market/ the public/ Promoter Type of No. and % Type of No. Value Transaction Type of No. and % of From To rights/ group/ securities of share- securities Type securities shareholding preferential Designated (For eg.- holding (For eg.- (Purchase/S (For eg.- offer/ off Person/Dire Shares, Shares, ale/ Pledge/ Shares, market/ inter- ctors/ Warrants, Warrants, Revocation/ Warrants, se transfer, Immediate Convertible Convertible Invocation/ Convertible ESOPs, etc.) Relative to/ debentures, debentures, Others- debentures, others etc. Rights Rights please Rights entitlement entitlement specify) entitlement etc.) etc.) etc.) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Sanofi Member of Equity Nil Equity 3,500,000 INR 10,68,20,00,000 Purchase Equity Shares 3,500,000 24/09/2026 24/09/2026 25/09/2026 An inter-se The National Healthcare India the Shares Shares (15.20%) transfer Stock Exchange Private Limited Promoter among of India Limited PAN: group members of AAECS6982Q the promoter and promoter Address: 2nd group of the Floor, Sanofi Target House, CTS No. Company 117-B, L&T through a Business Park, block deal Saki Vihar Road, mechanism Powai, Mumbai on the Stock 400 072 Exchange Phone No.+91(22) 2803 2000 Note: (i) "Securities" shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015. (ii) Value of transaction excludes taxes/brokerage/any other charges Details of trading in derivatives on the securities of the Company by Promoter, member of the promoter group, designated person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2). Trading in derivatives (Specify type of contract, Futures or Options etc.) Exchange on which Type of contract Contract Buy Sell the trade was Specifi- Notional No. of units Notional No. of executed cations value (contracts * value units lot size) (contracts * lot size) 16 17 18 19 20 21 22 Not Applicable Not Not Not Not Not Not Applicable Applicable Applicable Applicable Applicable Applicable Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options. For Sanofi Healthcare India Private Limited Neha Pukhraj Digitally signed by Neha Pukhraj Pokhrana Pokhrana Date: 2026.09.25 13:39:46 +05'30' Neha Pokhrana Company Secretary Membership No.A40082 Date: 25th September 2026 Place: Mumbai